Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made that effectively block a specific enzyme related to androgen conditions.

MK-386 lowers DHT in blood and skin but not in semen.

New retinoids are effective for various skin conditions and are being developed to have fewer side effects.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Neutrophils are key in causing chronic itch in atopic dermatitis, and blocking CXCR3 could reduce this itch.

Enilconazole and lime sulfur work well for whole body treatment, while other products need frequent application for effective antifungal action.

New acne treatments like clascoterone and minocycline foam are effective, and using antibiotics carefully is important to avoid resistance.

Combining injections with lotion is more effective for hair regrowth in alopecia areata than using the lotion alone.

Itraconazole helps improve tough skin infections but may not prevent them from coming back.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Eflornithine cream effectively reduces facial hair in women with hirsutism.

17β-estradiol can reduce inflammation in the skin.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.